305 related articles for article (PubMed ID: 15766010)
21. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
[TBL] [Abstract][Full Text] [Related]
22. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
Tsai WC; Lin CC; Chen JY; Huang YY; Lee CH; Li WT; Weng CM; Chen JH
Blood Press; 2008; 17(4):233-8. PubMed ID: 18671144
[TBL] [Abstract][Full Text] [Related]
23. Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women.
Kwon K; Jung SH; Choi C; Park SH
Int J Cardiol; 2005 Jun; 101(3):385-90. PubMed ID: 15907405
[TBL] [Abstract][Full Text] [Related]
24. Gender differences in association of plasma adiponectin with obesity reflect resultant insulin resistance in non-diabetic Japanese patients with schizophrenia.
Matsuda Y; Tanioka T; Yoshioka T; Nagano T; Hiroi T; Yoshikawa K; Okabe K; Nagamine I; Takasaka Y
Psychiatry Clin Neurosci; 2005 Jun; 59(3):266-73. PubMed ID: 15896219
[TBL] [Abstract][Full Text] [Related]
25. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians.
Nayak BS; Ramsingh D; Gooding S; Legall G; Bissram S; Mohammed A; Raychaudhuri A; Sahadeo B; Pandohie V; Figaro K
Prim Care Diabetes; 2010 Oct; 4(3):187-92. PubMed ID: 20580627
[TBL] [Abstract][Full Text] [Related]
26. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 6, adiponectin, leptin, and insulin resistance in nonobese Japanese type 2 diabetic patients.
Taniguchi A; Fukushima M; Ohya M; Nakai Y; Yoshii S; Nagasaka S; Matsumoto K; Taki Y; Kuroe A; Nishimura F; Seino Y
Metabolism; 2006 Feb; 55(2):258-62. PubMed ID: 16423635
[TBL] [Abstract][Full Text] [Related]
28. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin.
Aso Y; Yamamoto R; Wakabayashi S; Uchida T; Takayanagi K; Takebayashi K; Okuno T; Inoue T; Node K; Tobe T; Inukai T; Nakano Y
Diabetes; 2006 Jul; 55(7):1954-60. PubMed ID: 16804063
[TBL] [Abstract][Full Text] [Related]
29. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients.
Yun JE; Sull JW; Lee HY; Park E; Kim S; Jo J; Lee SJ; Kim SY; Choi YJ; Jee SH; Huh KB
Diabetes Metab Res Rev; 2009 Mar; 25(3):259-65. PubMed ID: 19214966
[TBL] [Abstract][Full Text] [Related]
30. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M
Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
[TBL] [Abstract][Full Text] [Related]
31. Serum leptin levels in female patients with NIDDM.
Haque Z; Rahman MA
J Coll Physicians Surg Pak; 2003 Mar; 13(3):130-4. PubMed ID: 12689528
[TBL] [Abstract][Full Text] [Related]
32. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.
Hasegawa G; Ohta M; Ichida Y; Obayashi H; Shigeta M; Yamasaki M; Fukui M; Yoshikawa T; Nakamura N
Acta Diabetol; 2005 Jun; 42(2):104-9. PubMed ID: 15944845
[TBL] [Abstract][Full Text] [Related]
33. Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children.
Chu NF; Shen MH; Wu DM; Lai CJ
Obes Res; 2005 Nov; 13(11):2014-20. PubMed ID: 16339134
[TBL] [Abstract][Full Text] [Related]
34. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.
Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A
Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282
[TBL] [Abstract][Full Text] [Related]
35. Serum adiponectin concentration and cardiovascular risk factors in climacteric women.
Milewicz A; Zatonska K; Demissie M; Jêdrzejuk D; Dunajska K; Ilow R; Lwow F
Gynecol Endocrinol; 2005 Feb; 20(2):68-73. PubMed ID: 15823824
[TBL] [Abstract][Full Text] [Related]
36. Decreased levels of plasma adiponectin in prediabetes, Type 2 diabetes and coronary artery disease.
Yaturu S; Bridges JF; Subba Reddy DR
Med Sci Monit; 2006 Jan; 12(1):CR17-20. PubMed ID: 16369465
[TBL] [Abstract][Full Text] [Related]
37. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
[TBL] [Abstract][Full Text] [Related]
38. Identification of influencing variables on adiponectin serum levels in diabetes mellitus type 1 and type 2.
Schäffler A; Herfarth H; Paul G; Ehling A; Müller-Ladner U; Schölmerich J; Zietz B
Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):383-9. PubMed ID: 15239024
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
Ahmad J; Ahmned F; Siddiqui MA; Khan AR; Katyal P; Hameed B; Ahmad I
J Assoc Physicians India; 2007 Oct; 55():693-9. PubMed ID: 18173021
[TBL] [Abstract][Full Text] [Related]
40. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.
Guebre-Egziabher F; Bernhard J; Funahashi T; Hadj-Aissa A; Fouque D
Nephrol Dial Transplant; 2005 Jan; 20(1):129-34. PubMed ID: 15585515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
